Wijsenbeek MS, Floricel F, Thonnard J, et al. A worldwide review of ‘real’ life’ practice: experience from a treatment feasibility review in 41 countries. ERS 2018, Parijs. Sessie 46; OA263.
Combinatie JAK-remmer en anti-PD-1 bij gemetastaseerd NSCLC
sep 2024 | Immuuntherapie, Longoncologie